Trials / Conditions / NRAS Gene Mutation
NRAS Gene Mutation
4 registered clinical trials studyying NRAS Gene Mutation — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies NCT05786924 | Institut de Recherches Internationales Servier | Phase 1 / Phase 2 |
| Completed | NAUTILUS: OKI-179 Plus Binimetinib in Patients with Advanced Solid Tumors in the RAS Pathway (Phase 1b) and NR NCT05340621 | OnKure, Inc. | Phase 1 / Phase 2 |
| Completed | OPTImal PALliative Anti-epidermal Growth Factor Receptor Treatment in Metastatic Colorectal Cancer - NCT03750175 | Karen-Lise Garm Spindler | — |
| Available | Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies NCT04566393 | xCures | — |